As 2019 begins, STAT reporters are taking a look at the stories they’re most eager to track during the year. Find all our “three to watch” series here.
WASHINGTON — There will be more than 100 new faces in the halls of Congress next year, many of whom have their own ideas for improving America’s health care and lowering the costs of prescription drugs. But the faces plastering the evening news aren’t the ones industry should be worried about.
While America’s attention was captured by Democratic upstarts Alexandria Ocasio-Cortez (N.Y.) and Rashida Tlaib (Mich.), who are pushing the slogan Medicare For All, lesser-known candidates were developing their own, often meticulously detailed plans on how to handle Obamacare and bring down prescription drug prices. And some of these lawmakers are already vying for influential positions in Congress, where they’ll have the power to put their plans in motion, with potentially far-reaching effects on patients, health care, and biopharmaceutical companies.
About the Author Reprints
Interesting story. Thank you for publishing this article. By Gregg L. Friedman MD